首页 > 市场调查报告书 > 製药

疫苗感染疾病

市场调查报告书

商品编码

1890959

Gardasil市场按疫苗类型、疾病预防适应症、接种方案、性别、年龄层、最终用户、分销管道和地区划分

Gardasil Market, By Vaccine Type, By Disease Prevention Indication, By Dosage Schedule, By Gender, By Age Group, By End User, By Distribution Channel, By Geography

出版日期: 2025年11月21日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

据估计，2025 年Gardasil市场规模为 51.4 亿美元，预计到 2032 年将达到 111.5 亿美元，2025 年至 2032 年的复合年增长率为 11.7%。

报告内容		报告详情
基准年：	2024	2025年市场规模：	51.4亿美元
历史数据时期：	2020-2024	预测期：	2025-2032
预测期间（2025-2032年）：	11.70%	2032 年的预测值：	111.5亿美元

全球Gardasil市场是预防保健和疫苗行业的重要组成部分，专注于透过接种疫苗来预防人类乳突病毒 (HPV) 感染。Gardasil疫苗由默克公司研发，可预防导致子宫颈癌、生殖器疣和其他 HPV 相关恶性肿瘤的主要原因—特定 HPV 病毒株。与最初针对 HPV 6、11、16 和 18 型的四价疫苗（Gardasil4）相比，目前的九价疫苗（Gardasil9）显着扩大了对九种 HPV 株的保护范围。

该市场涉及众多相关人员，包括製药企业、医疗服务提供者、政府卫生机构以及各个年龄层的终端用户。世界卫生组织 (WHO) 和美国疾病管制与预防中心 (CDC) 等国际卫生组织已将人类乳突病毒(HPV)疫苗推荐为一项重要的公共卫生措施，推动了其在已开发市场和新兴市场的广泛应用。市场动态受到多种因素的影响，例如人们对 HPV 相关疾病的认识不断提高、疫苗接种计划的扩展、核准用于更广泛的年龄组和性别群体，以及对全球医疗基础设施投资的增加，这些因素共同作用，使Gardasil成为综合癌症预防战略的关键组成部分。

市场动态

全球Gardasil市场的主要驱动力是人们对HPV相关癌症的认识不断提高，以及对疫苗接种在减轻疾病负担方面重要性的认识不断增强，尤其是在预防子宫颈癌（全球女性第四大常见癌症）方面的有效性。已开发国家政府主导的倡议和国家免疫规划显着加快了市场渗透，许多国家已将人类乳突病毒(HPV)疫苗纳入青少年常规免疫接种计划。目标人口从最初的女性群体扩大到男性群体，显着扩大了潜在市场，因为卫生部门认识到性别中立的疫苗接种策略对于实现群体免疫和降低HPV感染率的重要性。疫苗製剂的技术进步，特别是从四价疫苗到九价Gardasil的过渡，扩大了保护范围并提升了其市场地位。

然而，市场仍面临诸多限制因素。疫苗价格高昂限制了价格敏感地区的疫苗取得，文化和宗教障碍也影响疫苗接种的接受度，尤其是在性行为感染传染病被视为禁忌的保守社会。复杂的供应链和冷藏保管要求也带来了额外的挑战，尤其是在医疗基础设施不足的开发中国家。疫苗冷藏和虚假宣传活动也导致部分民众犹豫不决，影响疫苗接种率。然而，新兴市场蕴藏着巨大的机会和成长潜力，这些市场医疗支出不断增长，公众意识不断提高，医疗基础设施也不断完善。製药公司与国际卫生组织进行策略合作，制定价格合理的疫苗分发计划，核准疫苗用于更广泛的年龄群体，并持续进行潜在治疗用途的临床研究，这些都为市场扩张和改善全球健康状况提供了可观的途径。

本次调查的主要特点

本报告对全球Gardasil市场进行了详细分析，以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和復合年增长率（%）。
它还重点介绍了各个细分市场的潜在商机，并为该市场说明了一个有吸引力的投资提案矩阵。
该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要参与企业。
本报告基于以下几个方面，对全球Gardasil市场的主要企业进行了分析：公司概况、产品系列、主要特征、财务表现和策略。
本报告的研究结果将帮助负责人和经营团队就即将推出的产品、类型升级、市场扩张和行销策略做出明智的决策。
这份全球Gardasil市场报告的目标受众是该行业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
相关人员可以透过全球Gardasil市场分析中使用的各种策略矩阵轻鬆做出决策。

北美洲
- 美国
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲国家
欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲
亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 亚太其他地区
中东
- GCC
- 以色列
- 其他中东国家
非洲
- 南非
- 北非
- 中非

第十二章竞争格局

Merck & Co., Inc.

第十三章分析师建议

机会
一致的机会地图

第十四章参考文献与调查方法

参考
调查方法
关于出版商

简介目录

Product Code: CMI8975

Gardasil Market is estimated to be valued at USD 5.14 Bn in 2025 and is expected to reach USD 11.15 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.7% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 5.14 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	11.70%	2032 Value Projection:	USD 11.15 Bn

The global Gardasil market represents a critical segment within the preventive healthcare and vaccine industry, focusing on human papillomavirus (HPV) prevention through immunization. Gardasil, developed by Merck & Co., is a prophylactic vaccine designed to protect against specific strains of HPV that are primarily responsible for cervical cancer, genital warts, and other HPV-related malignancies. The vaccine has evolved from its original quadrivalent formulation (Gardasil 4) targeting HPV types 6, 11, 16, and 18, to the current nonavalent version (Gardasil 9) that provides protection against nine HPV strains, significantly expanding its preventive capabilities.

The market encompasses various stakeholders including pharmaceutical manufacturers, healthcare providers, government health agencies, and end-users across different age demographics. Global health organizations, including the World Health Organization and Centers for Disease Control and Prevention, have endorsed HPV vaccination as a crucial public health intervention, driving widespread adoption across developed and emerging markets. The market dynamics are influenced by factors such as increasing awareness of HPV-related diseases, expanding vaccination programs, regulatory approvals for broader age groups and gender inclusion, and growing healthcare infrastructure investments worldwide, positioning Gardasil as an essential component of comprehensive cancer prevention strategies.

Market Dynamics

The global Gardasil market is primarily driven by escalating awareness regarding HPV-related cancers and the critical role of preventive vaccination in reducing disease burden, particularly cervical cancer which represents the fourth most common cancer among women worldwide. Government initiatives and national immunization programs across developed countries have significantly accelerated market adoption, with many nations including HPV vaccination in their routine immunization schedules for adolescents. The expansion of target demographics beyond the initial female population to include males has substantially broadened the addressable market, as healthcare authorities recognize the importance of gender-neutral vaccination strategies in achieving herd immunity and reducing overall HPV transmission. Technological advancements in vaccine formulation, particularly the transition from quadrivalent to nonavalent Gardasil, have enhanced protection coverage and improved market positioning.

However, the market faces considerable restraints including high vaccine costs that limit accessibility in price-sensitive regions, cultural and religious barriers affecting vaccination acceptance, particularly in conservative societies where discussions about sexually transmitted infections remain taboo. Supply chain complexities and cold storage requirements pose additional challenges, especially in developing countries with inadequate healthcare infrastructure. Anti-vaccine sentiment and misinformation campaigns have also created hesitancy among certain population segments, impacting uptake rates. Nevertheless, substantial opportunities exist in emerging markets where increasing healthcare spending, growing awareness campaigns, and expanding healthcare infrastructure present significant growth potential. Strategic partnerships between pharmaceutical companies and international health organizations for affordable vaccine distribution programs, coupled with ongoing clinical research for expanded age group approvals and potential therapeutic applications, represent promising avenues for market expansion and improved global health outcomes.

Key Features of the Study

This report provides in-depth analysis of the global Gardasil market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global Gardasil market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck & Co. Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Gardasil market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Gardasil market

Market Segmentation

Vaccine Type Insights (Revenue, USD Bn, 2020 - 2032)
- Gardasil (Quadrivalent)
- Gardasil 9 (Nonavalent)
Disease Prevention Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Cervical Cancer Prevention
- Vulvar and Vaginal Cancer Prevention
- Anal Cancer Prevention
- Oropharyngeal Cancer Prevention
- Genital Warts Prevention
Dosage Schedule Insights (Revenue, USD Bn, 2020 - 2032)
- 2-Dose Schedule
- 3-Dose Schedule
Gender Insights (Revenue, USD Bn, 2020 - 2032)
- Male
- Female
Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Adolescents (typically 9-14 years)
- Young adults (15-26 years)
- Adults (above 26 years)
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals and Multispecialty Centers
- Pediatric and Gynecology Clinics
- Academic and Research Institutions
- Corporate, Workplace Vaccination Programs
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Public sector
- Private sector
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Merck & Co., Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Gardasil Market, By Vaccine Type
- Global Gardasil Market, By Disease Prevention Indication
- Global Gardasil Market, By Dosage Schedule
- Global Gardasil Market, By Gender
- Global Gardasil Market, By Age Group
- Global Gardasil Market, By End User
- Global Gardasil Market, By Distribution Channel
- Global Gardasil Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Gardasil Market, By Vaccine Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Gardasil (Quadrivalent)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gardasil 9 (Nonavalent)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Gardasil Market, By Disease Prevention Indication, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cervical Cancer Prevention
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Vulvar and Vaginal Cancer Prevention
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Anal Cancer Prevention
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oropharyngeal Cancer Prevention
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Genital Warts Prevention
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Gardasil Market, By Dosage Schedule, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
2-Dose Schedule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
3-Dose Schedule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Gardasil Market, By Gender, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Gardasil Market, By Age Group, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Adolescents (typically 9-14 years)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Young adults (15-26 years)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Adults (above 26 years)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Gardasil Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals and Multispecialty Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pediatric and Gynecology Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Corporate, Workplace Vaccination Programs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Gardasil Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Public sector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Private sector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Gardasil Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Prevention Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Schedule, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Prevention Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Schedule, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Prevention Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Schedule, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Prevention Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Schedule, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Prevention Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Schedule, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Prevention Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Schedule, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

12. Competitive Landscape

Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

13. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

14. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

Gardasil市场按疫苗类型、疾病预防适应症、接种方案、性别、年龄层、最终用户、分销管道和地区划分

Gardasil Market, By Vaccine Type, By Disease Prevention Indication, By Dosage Schedule, By Gender, By Age Group, By End User, By Distribution Channel, By Geography

市场动态

目录

第一章研究目标与前提条件

第二章市场范围

第三章：市场动态、监理及趋势分析

4. 2020-2032年全球Gardasil市场（依疫苗类型划分）

5. 2020-2032年全球Gardasil市场依疾病预防适应症划分

6. 2020-2032年全球Gardasil市场依接种时间划分

7. 2020-2032年全球Gardasil市场依性别划分

8. 2020-2032年全球Gardasil市场依年龄层划分

9. 2020-2032年全球Gardasil市场（依最终用户划分）

10. 2020-2032年全球Gardasil市场依通路划分

11. 2020-2032年全球Gardasil市场区域分布